4//SEC Filing
Epizyme, Inc. 4
Accession 0001209191-17-029545
CIK 0001571498operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 1:08 PM ET
Size
9.1 KB
Accession
0001209191-17-029545
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Copeland Robert A
EVP and CSO10% Owner
Transactions
- Exercise/Conversion
Commons Stock, par value $0.0001
2017-05-02$3.54/sh+5,000$17,700→ 36,538 total - Sale
Commons Stock, par value $0.0001
2017-05-02$17.44/sh−5,000$87,213→ 31,538 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-05-02−5,000→ 38,550 totalExercise: $3.54Exp: 2023-01-24→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.40 per share to $17.65 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F3]This option is fully vested.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001571498
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 1:08 PM ET
- Size
- 9.1 KB